The biotech space is not for the faint hearted, given the ebbs and flows in terms of the returns from investing in it. However, for one who perseveres and astutely devises strategies with full cognizance of key regulatory events coming up, the probability of drug candidates getting FDA's blessings and sympathy plays in the space, it provide a sea of opportunity and huge upside prospects.
from RTT - Biotech http://ift.tt/2d8TDLy
via IFTTT
No comments:
Post a Comment